Data & Intelligence

Impact Case Study: Biosensors International Group

Hony Capital invested US$200 million for a 24.8% stake in the company.

  • Company Headquarters: Singapore
  • Business focus: Medical devices

ImPACT HIGHLIGHTS

  • As a financial backer and strategic local partner, Hony Capital helped Biosensors align interests amongst all shareholders in its Chinese joint venture, JW Medical, and expand its business in China

  • Between FY 2010 and FY 2012, Biosensors grew revenues from SGD147 million to SGD369 million, a CAGR of 59%, while increasing its gross margins by 7.7 percentage points

  • Biosensors has grown its business in China from 9% of its total revenue in FY 2011 to 21% of its total revenue in FY 2012

  • Biosensors’s pioneering drug-eluting technology has helped the company to penetrate markets in 70 countries

DOWNLOAD FULL STUDY

Hony-Case-Study-Listing.jpg
EMPEA has served as a useful reference platform for CDPQ by helping to define the eligible universe of fund managers in growth markets. Membership provides background data and a...

Rashad Kaldany | Executive Vice-President and Growth Markets, CDPQ

The developed markets have no equivalent to the role EMPEA is playing as a convener and source of trusted information in the emerging markets.

David Rubenstein | Co-Founder and Managing Director, The Carlyle Group